Completed PHASE3 INTERVENTIONAL 2-arm NCT02195297

Evaluation of the Activity of a Pharmacological Anticellulitis Product vs. a Reference Product on the Market

Clinical and Instrumental Evaluation of the Activity of a Pharmacological Anticellulitis Product vs. a Reference Product on the Market: Comparison Within Subjects (Double Blind Study)

Sponsor: Derming SRL

Conditions Healthy

Interventions ANTICELLULITE GMG GIULIANI Cream and SOMATOLINE Cream

Updated 5 times since 2017 Last updated: Jul 17, 2014 Started: Sep 30, 2013 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02195297, this PHASE3 trial focuses on Healthy and remains completed. Sponsored by Derming SRL, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Derming SRL

Data source: Derming SRL

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.